Assertio Holdings (ASRT) EBITDA Margin (QoQ) (2019 - 2026)
Assertio Holdings (ASRT) EBITDA Margin (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,818.00 |
| Dec 31, 2025 | -11,017.00 |
| Sep 30, 2025 | 5,056.00 |
| Jun 30, 2025 | 2,243.00 |
| Mar 31, 2025 | -802.00 |
| Dec 31, 2024 | -3,146.00 |
| Sep 30, 2024 | 120.00 |
| Jun 30, 2024 | 176.00 |
| Mar 31, 2024 | 16,091.00 |
| Dec 31, 2023 | 61,067.00 |
| Sep 30, 2023 | -80,530.00 |
| Jun 30, 2023 | 2,887.00 |
| Mar 31, 2023 | -18,408.00 |
| Dec 31, 2022 | 16,367.00 |
| Sep 30, 2022 | -1,010.00 |
| Jun 30, 2022 | -251.00 |
| Mar 31, 2022 | 1,099.00 |
| Dec 31, 2021 | -85.00 |
| Sep 30, 2021 | 7,051.00 |
| Jun 30, 2021 | -7,277.00 |